
Personalizing Surgical Risk Assessment in Lung Cancer With AI
10/09/2026
0:00
16:29
Read the full article here: https://oncdata.com/personalizing-surgical-risk-assessment-in-lung-cancer
For many patients with lung cancer, surgery offers the best chance for cure and long-term survival, but that opportunity can come with meaningful risk—particularly for older patients with smoking histories, reduced lung function, frailty, or other medical conditions. In this episode of Exploring AI in Oncology, Waqas Haque, MD, MPH, Hematology/Oncology Fellow at the University of Chicago, speaks with Dr. Kenneth Patrick Seastedt, Thoracic Surgeon at Roswell Park Comprehensive Cancer Center, about MIRACLE, an AI-enabled platform designed to help predict postoperative pulmonary complications after lung cancer surgery. By combining clinical data, radiomic information extracted from CT imaging, and large language model (LLM)–generated risk explanations, the platform creates a more personalized assessment of surgical risk—all while keeping surgeons involved in every stage of interpretation and decision making.
Mais episódios de "Oncology Data Advisor"



Não percas um episódio de “Oncology Data Advisor” e subscrevê-lo na aplicação GetPodcast.








